Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients

BACKGROUND: The use of circulating tumor cells (CTCs) as indicators of treatment response in metastatic colorectal cancer (mCRC) needs to be clarified. The objective of this study is to compare the Response Evaluation Criteria in Solid Tumors (RECIST) with the Cytologic Criteria Assessing Response (...

Descripción completa

Detalles Bibliográficos
Autores principales: Delgado-Ureña, Mayte, Ortega, Francisco G., de Miguel-Pérez, Diego, Rodriguez-Martínez, Alba, García-Puche, Jose L., Ilyine, Hugh, Lorente, Jose A., Exposito-Hernandez, Jose, Garrido-Navas, M. Carmen, Delgado-Ramirez, Miguel, Serrano, M. José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127986/
https://www.ncbi.nlm.nih.gov/pubmed/30189880
http://dx.doi.org/10.1186/s12967-018-1624-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127986/
https://www.ncbi.nlm.nih.gov/pubmed/30189880
http://dx.doi.org/10.1186/s12967-018-1624-2

Ejemplares similares